Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

THRX Company Profile and Key Details

NASDAQ : THRX

Theseus Pharmaceuticals, Inc.

$4.07
0.005+0.12%
At Close 4:00 PM
Not Actively Trading
64.42
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

THRX Stock Price Chart

Stock Price Today

Theseus Pharmaceuticals, Inc. (THRX) stock surged +0.12%, trading at $4.07 on NASDAQ, up from the previous close of $4.06. The stock opened at $4.06, fluctuating between $4.06 and $4.07 in the recent session.

Stock Snapshot

4.06
Prev. Close
4.06
Open
181.5M
Market Cap
44.65M
Number of Shares
4.06
Day Low
4.07
Day High
-3.033582089552239
P/E Ratio
31.95%
Free Float in %
-1.34
EPS (TTM)
5.13
Book Value
-1.13
Cash Flow per Share
677.69K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 23, 20244.064.064.064.060
Feb 22, 20244.064.064.064.060
Feb 20, 20244.064.064.064.060
Feb 16, 20244.064.064.064.060
Feb 15, 20244.064.064.064.060
Feb 14, 20244.064.064.064.060
Feb 13, 20244.064.074.064.063.12M
Feb 12, 20244.074.084.064.06231.1K
Feb 09, 20244.074.094.074.07121.98K
Feb 08, 20244.094.094.064.06327.4K
Feb 07, 20244.084.114.074.081.85M
Feb 06, 20244.074.084.074.08149.46K
Feb 05, 20244.064.074.054.07610.1K
Feb 02, 20244.064.084.064.06187.71K
Feb 01, 20244.084.094.064.08824.64K
Jan 31, 20244.084.084.054.06541.65K
Jan 30, 20244.084.104.064.06578.96K
Jan 29, 20244.014.043.994.03264.35K
Jan 26, 20244.014.023.994.00176.86K
Jan 25, 20244.024.033.993.99292.08K

Contact Details

Cambridge, MA 02142

United States

Website: https://theseusrx.comContact: 857 400 9491

About Company

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Company Information

Employees38
Beta3.98
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Theseus Pharmaceuticals, Inc. (THRX) stock price?
Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) stock price is $4.07 in the last trading session. During the trading session, THRX stock reached the peak price of $4.07 while $4.06 was the lowest point it dropped to. The percentage change in THRX stock occurred in the recent session was 0.12% while the dollar amount for the price change in THRX stock was $0.01.
THRX's industry and sector of operation?
The NASDAQ listed THRX is part of Biotechnology industry that operates in the broader Healthcare sector. Theseus Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of THRX?
Dr. Timothy P. Clackson Ph.D.
Chief Executive Officer, Pres & Director
Mr. Wei-Sheng Huang Ph.D.
Co-Founder & Senior Vice President of Chemistry
Dr. William C. Shakespeare Ph.D.
Co-Founder and Pres of R&D
Mr. Len Rozamus
Senior Vice President of Technical Operations
Mr. Bradford D. Dahms
Chief Financial officer
Dr. Alicja Januszewicz Ph.D.
Senior Vice President of People & Culture
Dr. Iain D. Dukes D.Phil., DPHIL, M.A.
Co-Founder & Chairman
Mr. Benjamin D. Enerson
Vice President of Legal Affairs
Dr. Nachu Narasimhan Ph.D.
Senior Vice President of Drug Metabolism & Preclinical Safety
Dr. David P. Kerstein M.D.
Chief Medical Officer
Dr. Victor M. Rivera Ph.D.
Co-Founder, Senior Vice President & Chief Scientific Officer
How THRX did perform over past 52-week?
THRX's closing price is 98.29% higher than its 52-week low of $2.05 where as its distance from 52-week high of $12.37 is -67.14%.
How many employees does THRX have?
Number of THRX employees currently stands at 38.
Link for THRX official website?
Official Website of THRX is: https://theseusrx.com
How do I contact THRX?
THRX could be contacted at phone 857 400 9491 and can also be accessed through its website. THRX operates from 245 Main Street, Cambridge, MA 02142, United States.
How many shares of THRX are traded daily?
THRX stock volume for the day was 677.69K shares. The average number of THRX shares traded daily for last 3 months was 849.6K.
What is the market cap of THRX currently?
The market value of THRX currently stands at $181.50M with its latest stock price at $4.07 and 44.65M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Categories

InvestingCrypto NewsMarket NewsBusinessUS Stocks

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades and Downgrades52 Week Highs LowsUnusual VolumeDividend CalenderEarnings Calender
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph